Cannabis Recommendation Information System
Cannabis has been used medicinally for thousands of years in many cultures. Up until December 2020, cannabis was in Schedule IV of the United Nations’ Single Convention on Narcotic Drugs, which subjected it to special restrictions; and consequently, modern medicine has not rigorously examined, tested, and clinically validated its safety and efficacy on treating diseases.
Limited evidence has suggested cannabis can reduce nausea and vomiting during chemotherapy, increase appetite in patients with HIV/AIDS, reduce chronic pain and muscle spasms, and manage severe forms of epilepsy, especially in children. Recently, for chronic pain, an expert scientific committee (physicians and clinicians – Canada and USA) developed consensus-based recommendations on how to effectively titrate cannabinoids and taper opioids.
Through our clinical decision support tool C/R/I/S (based on underlying select clinical data/knowledge and the use of AI/ML algorithms that determine optimized recommendations), we are able to select the most appropriate medical cannabis product from Health Canada licensed facilities, initiate and titrate dosing, check for cannabis-drug interactions, schedule follow-up appointments, and manage outcomes.
Key security highlights of the C/R/I/S platform:
end-to-end encryption, secure and private
complies with the Personal Health Information Protection Act (PHIPA), the Personal Information Protection and Electronic Documents Act (PIPEDA), and all equivalent personal health information protection legislation in Canada